Novus Therapeutics (NVUS) Releases Earnings Results, Misses Expectations By $0.09 EPS - Fairfield Current

Novus Therapeutics (NVUS) Releases Earnings Results, Misses Expectations By $0.09 EPS  Fairfield Current

Novus Therapeutics (NASDAQ:NVUS) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.49) earnings per share ...



Comments

Popular posts from this blog

Uveitis Eye Inflammation Causes, Symptoms & Treatment

Robert Zakar gives back to community

Goopy Eyes: Causes and Treatment